179 related articles for article (PubMed ID: 36281290)
1. Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas.
Feng X; Chen Y; Liu X; Zhong Z; Liu Y
J Oncol; 2022; 2022():7043431. PubMed ID: 36281290
[TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas.
Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L
Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
4. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.
Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y
Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808
[No Abstract] [Full Text] [Related]
6. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer.
Zhuang Z; Cai H; Lin H; Guan B; Wu Y; Zhang Y; Liu X; Zhuang J; Guan G
J Oncol; 2021; 2021():5818512. PubMed ID: 34840571
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
9. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
10. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas.
Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J
Front Genet; 2023; 14():1087563. PubMed ID: 36861130
[No Abstract] [Full Text] [Related]
12. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
Front Oncol; 2022; 12():780950. PubMed ID: 35280739
[TBL] [Abstract][Full Text] [Related]
13. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma.
Xia F; Yan Y; Shen C
Front Cell Dev Biol; 2021; 9():811734. PubMed ID: 34966747
[TBL] [Abstract][Full Text] [Related]
16. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
17. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients.
Wu J; Lu L; Wang C; Jiang F
J Oncol; 2022; 2022():8164756. PubMed ID: 35646114
[TBL] [Abstract][Full Text] [Related]
18. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
19. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
Front Genet; 2022; 13():966896. PubMed ID: 36186456
[No Abstract] [Full Text] [Related]
20. Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature.
Lu L; Zhang P; Cao X; Guan M
J Oncol; 2022; 2022():1539659. PubMed ID: 35432539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
